Scripps Research Logo

News Release

Study Led by Scripps Research Scientist Reveals Little-Known Cell Networks Vital to Circadian Rhythm

New Findings Point to Strategic Shift in Future Research, Potential Therapies

LA JOLLA, CA, May 3, 2007—In a wide-ranging systems biology study of circadian rhythm, a multi-institutional collaboration led by Scripps Research Institute Professor Steve Kay has uncovered some little-known cellular mechanisms for sustaining circadian rhythm and limiting the impact of genetic clock mutations in mammals. The new findings could have important implications for future circadian studies, and point researchers toward new ways to manipulate human circadian rhythm at the molecular level to treat diseases such as bipolar disorder.

The new study was published in the May 3, 2007 (Volume 129, Issue 3) edition of the journal Cell.

Circadian rhythm is the basic 24-hour cycle that involves various behaviors, including sleeping and eating, in all living organisms. In mammals, the circadian clock is organized hierarchically in a series of multiple oscillators. At the top of this hierarchy, the suprachiasmatic nucleus (SCN), a region of the brain that is the body's main rhythmic regulator, integrates light information from the eyes and coordinates peripheral oscillators throughout the body.

By examining effects of genetic mutations at the level of single cells and tissues, the study showed that intercellular mechanisms are in fact essential to the operation of cellular circadian clocks.

"Our study reveals some previously overlooked mechanisms for sustaining cellular circadian rhythm," said Steve A. Kay, whose laboratory spearheaded the research. "Essentially, when cells communicate en masse through these highly networked electrical or neurochemical interactions, the system responds far more effectively."

The SCN intercellular network, Kay said, is necessary not only to stabilize oscillators in the peripheral tissues but also to provide a robust response to various genetic mutations. In fact, the network interactions unique to the SCN can compensate for some genetic defects in the Period (Per) and Cryptochrome (Cry) genes—the clock genes—to preserve circadian rhythm.

In fact, the circadian defects observed in mutant oscillators were clearly more extreme when measured at the tissue and cell levels than demonstrated by behavioral observations.

"Because single cells are ordinarily capable of functioning as autonomous oscillators," Kay noted, "our previous understanding of clock mechanisms has rested precariously on the idea that if we studied behavior, we could assume that same thing was happening at the single cell level. Our study shows that's not the case."

The lack of networked interactions in peripheral tissues may actually be an adaptive feature in most circumstances. SCN cells in vivo must synchronize not only to light-dark cycles but also to one another to coordinate circadian behavior. Lack of coupling may allow peripheral oscillators to anticipate and respond rapidly not only to the synchronizing cues emanating from the SCN but also to physiological signals related to feeding and behavior.

"Future studies should focus on addressing the system impact of these cellular networks," Kay said. "Our results validate clock model predictions previously overlooked or sometimes regarded as model flaws. Newer models are needed to accommodate the novel cell-autonomous phenotypes we uncovered."

Other authors of the study, Intercellular Coupling Confers Robustness against Mutations in the SCN Circadian Clock Network, include Aaron A. Priest of The Scripps Research Institute; Andrew C. Liu, Hien G. Tran and Eric E. Zhang of The Scripps Research Institute and Genomics Institute of the Novartis Research Foundation; David K. Walsh of The Scripps Research Institute, The University of California, San Diego, and Veterans Affairs San Diego Healthcare System; Oded Singer and Inder M. Verma of the Salk Institute for Biological Studies; Ethan D. Buhr of Northwestern University; Kirsten Meeker of the University of California, SB; Francis J. Doyle of the University of California, Santa Barbara, and; Joseph S. Takahashi of Howard Hughes Medical Institute and Northwestern University.

The study was supported by the National Institutes of Health.

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Scripps Research is headquartered in La Jolla, California. It also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Currently operating from temporary facilities in Jupiter, Scripps Florida will move to its permanent campus in 2009.

For more information contact:
Office of Communications
10550 North Torrey Pines Road
La Jolla, California 92037